951 total citations 110 papers, 617 citations indexed
About
Ban Ta is a scholar working on Psychiatry and Mental health, Pharmacology and Molecular Biology.
According to data from OpenAlex, Ban Ta has authored 110 papers receiving a total of 617 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Psychiatry and Mental health, 16 papers in Pharmacology and 10 papers in Molecular Biology. Recurrent topics in Ban Ta's work include Schizophrenia research and treatment (20 papers), Treatment of Major Depression (14 papers) and Electroconvulsive Therapy Studies (10 papers). Ban Ta is often cited by papers focused on Schizophrenia research and treatment (20 papers), Treatment of Major Depression (14 papers) and Electroconvulsive Therapy Studies (10 papers). Ban Ta collaborates with scholars based in Canada. Ban Ta's co-authors include Lehmann He, Wilson Wh, G Chouinard, Mohamed A. Ragheb, Maiko Fujimori, S.M. Berney, Marcus-André Deutsch, Mohamed Amin, Melanie Deutsch and John M. Scott and has published in prestigious journals such as PubMed and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).
In The Last Decade
Ban Ta
94 papers
receiving
493 citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Ban Ta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ban Ta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ban Ta more than expected).
This network shows the impact of papers produced by Ban Ta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ban Ta. The network helps show where Ban Ta may publish in the future.
Co-authorship network of co-authors of Ban Ta
This figure shows the co-authorship network connecting the top 25 collaborators of Ban Ta.
A scholar is included among the top collaborators of Ban Ta based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Ban Ta. Ban Ta is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Ta, Ban. (1979). Amoxapine and viloxazine: review of the literature with special reference to clinical studies.. PubMed. 15(3). 22–5.8 indexed citations
3.
Ta, Ban, et al.. (1978). Trimipramine in the treatment of depression: a comparison of single vs. divided dose administration.. PubMed. 14(1). 42–3.1 indexed citations
4.
Ta, Ban, et al.. (1978). Nomifensin in the treatment of depression: a standard-controlled clinical study.. PubMed. 14(1). 37–9.3 indexed citations
5.
Ta, Ban. (1978). Some recent biochemical findings with possible therapeutic implications for schizophrenia.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 39(6). 535–6, 541.3 indexed citations
6.
Ta, Ban, et al.. (1977). Clomipramine (Anafranil) and behaviour therapy in obsessive-compulsive and phobic disorders.. PubMed. 5 Suppl 5. 33–7.10 indexed citations
7.
Ta, Ban, et al.. (1977). A standard-controlled clinical study with benzquinamide in the treatment of chronic schizophrenic patients.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 13(3). 20–1.4 indexed citations
8.
Ta, Ban & Lehmann He. (1977). Myths, theories and treatment of schizophrenia.. PubMed. 38(9). 665–71.2 indexed citations
9.
Ta, Ban, et al.. (1976). Proceedings: Trazodone: clinical and biochemical studies I. An uncontrolled clinical trial in depression.. PubMed. 12(1). 43–4.5 indexed citations
10.
He, Lehmann & Ban Ta. (1975). CNS stimulants and anabolic substances in geropsychiatric therapy.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 11(4). 51–51.
11.
Ta, Ban. (1975). Clinical psychopharmacology and psychiatry.. PubMed. 36(11). 612–6.2 indexed citations
12.
Ta, Ban, et al.. (1971). Lack of indication for use of antiparkinson medication. A follow-up study.. PubMed. 32(8). 538–41.4 indexed citations
13.
Chouinard, G, et al.. (1970). Fluspirilene in the treatment of chronic schizophrenic patients.. PubMed. 12(9). 604–8.11 indexed citations
14.
Deutsch, Melanie, et al.. (1970). Combined administration of thioridazine and fluoxymesterone in the treatment of geriatric patients.. PubMed. 12(12). 805–9.2 indexed citations
15.
Ta, Ban, et al.. (1968). Predictors of therapeutic responsivity to thiothixene in schizophrenics.. PubMed. 1(5). 394–6.1 indexed citations
16.
Amin, Masoud, et al.. (1967). Mesoridazine in acute psychotic disturbances.. PubMed. 9(12). 623–5.3 indexed citations
17.
Ta, Ban, et al.. (1966). The effect of a protriptyline-perphenazine combination in chronic psychiatric patients.. PubMed. 8(10). 483–6.5 indexed citations
18.
Ta, Ban, et al.. (1966). The effect of iminodibenzyls in the treatment of chronic psychotic patients.. PubMed. 8(4). 164–5.4 indexed citations
19.
He, Lehmann, et al.. (1964). A COMPARATIVE STUDY OF THIRTEEN HYPNOTIC DRUGS.. PubMed. 6. 806–9.1 indexed citations
20.
Ta, Ban, et al.. (1963). SYSTEMATIC STUDIES WITH LEVOMEPROMAZINE.. PubMed. 4. 112–7.7 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.